Related Experiment Video
Updated: Jun 3, 2026

Isolation of Viral Replication Compartment-enriched Sub-nuclear Fractions from Adenovirus-infected Normal Human Cells
Published on: November 12, 2015
[Experimental study of Ingavirin antiviral activity against human adenovirus]
Abstract:
Antiviral properties of Ingavirin were investigated in the Hep-2 cell culture with respect to the human respiratory tract virus (type 5 adenovirus). In concentrations of Ingavirin of 1000, 100 and 10 mcg/ml the generated posterity showed lower infective capacity (by 250, 100 and 10 times respectively). The electron microscopy of the infected cells confirmed the Ingavirin ability to disturb the adenovirus normal morphogenesis.
Insights
Ingavirin exhibits antiviral properties against human respiratory tract viruses like adenovirus. This study shows Ingavirin effectively reduces virus infectivity and disrupts adenovirus development in cell cultures.
Area of Science:
- Virology
- Cell Biology
- Pharmacology
Background:
- Human respiratory tract infections pose a significant health burden.
- Adenovirus type 5 is a common cause of respiratory illness.
- Developing effective antiviral agents is crucial for public health.
Purpose of the Study:
- To investigate the antiviral properties of Ingavirin.
- To assess Ingavirin's efficacy against human respiratory tract virus (type 5 adenovirus).
- To understand Ingavirin's mechanism of action on adenovirus replication.
Main Methods:
- Utilized Hep-2 cell cultures for antiviral assays.
- Exposed cells to type 5 adenovirus and varying concentrations of Ingavirin (1000, 100, 10 mcg/ml).
- Employed electron microscopy to examine viral morphogenesis in infected cells.
Main Results:
- Ingavirin demonstrated dose-dependent reduction in viral infective capacity.
- Observed reductions in infectivity by 250, 100, and 10 times at 1000, 100, and 10 mcg/ml, respectively.
- Electron microscopy confirmed Ingavirin disrupts adenovirus normal morphogenesis.
Conclusions:
- Ingavirin possesses significant antiviral activity against type 5 adenovirus.
- The drug interferes with the virus's structural development and replication cycle.
- Ingavirin shows potential as a therapeutic agent for adenovirus infections.
Related Concept Videos
Inhibitors Of Virion Release
Antiviral Nucleoside Inhibitors
Inhibitors of Virion Maturation and Assembly

